Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198000 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy of Investigational OTC Eye Drops
A Phase 3 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT03198000 is a Phase 3 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 120 participants.
The verdict
NCT03198000, a Phase 3 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
This is a single center, double-blinded study designed to demonstrate the therapeutic equivalence of over-the-counter eye drops in healthy adults with red eyes.
Interventions
- DRUG F# 13418-148 Eye Drops
- DRUG F#13418-158 Eye Drops
- DRUG F# PF-004390 Eye Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2017-07-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03198000
The ClinicalTrials.gov registry entry for NCT03198000 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which F# 13418-148 Eye Drops is the first listed.
NCT03198000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03198000 about?
NCT03198000 is a clinical study titled "A Study to Evaluate the Efficacy of Investigational OTC Eye Drops". This is a single center, double-blinded study designed to demonstrate the therapeutic equivalence of over-the-counter eye drops in healthy adults with red eyes.
What is the current status of trial NCT03198000?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2017-06-28. Estimated completion is 2017-07-21.
What interventions are being tested in trial NCT03198000?
The interventions under investigation include: F# 13418-148 Eye Drops (DRUG), F#13418-158 Eye Drops (DRUG), F# PF-004390 Eye Drops (DRUG).
Who is sponsoring clinical trial NCT03198000?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.